Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery
Open Access
- 28 May 2018
- journal article
- research article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 38 (3) , 204-211
Abstract
Yang HS, et al. Ann Lab Med. 2018 May;38(3):204-211. https://doi.org/10.3343/alm.2018.38.3.204Keywords
This publication has 30 references indexed in Scilit:
- Myocardial Injury After Noncardiac Surgery and its Association With Short-Term MortalityCirculation, 2013
- The Presage ® ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2Expert Review of Molecular Diagnostics, 2013
- Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgeryBritish Journal of Anaesthesia, 2012
- Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac SurgeryJAMA, 2012
- Systematic Review: Prediction of Perioperative Cardiac Complications and Mortality by the Revised Cardiac Risk IndexAnnals of Internal Medicine, 2010
- The Problem With Composite End Points in Cardiovascular StudiesJACC, 2008
- Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate riskCanadian Medical Association Journal, 2005
- Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac SurgeryNew England Journal of Medicine, 2005
- Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac SurgeryCirculation, 1999
- The Department of Veterans Affairs' NSQIPAnnals of Surgery, 1998